Skip to content
Open access · CC-BY via OpenAlex

Bioengineering the metabolic network of CAR T cells with GLP-1 and Urolithin A increases persistence and long-term anti-tumor activity

Areej Akhtar, Md Shakir, Mohammad Sufyan Ansari, Divya, Md Imam Faizan, Varnit Chauhan, Aashi Singh, Raquib Alam, Iqbal Azmi, Sheetal Sharma, Mehak Pracha, Insha Mohi Uddin, Uzma Bashir, Syeda Najidah Shahni, Rituparna Kundu Chaudhuri

Cell Reports Medicine · 2025 · ▲ 22 citations

Abstract

Constant tumor antigen exposure disrupts chimeric antigen receptor (CAR) T cell metabolism, limiting their persistence and anti-tumor efficacy. To address this, we develop metabolically reprogrammed CAR (MCAR) T cells with enhanced autophagy(definition) and mitophagy. A compound screening identifies a synergy between GLP-1R agonist (semaglutide [SG]) and Urolithin A (UrA), which activate autophagy through mTOR(definition) (mechanistic target of rapamycin(definition)) inhibition and mitophagy via Atg4b activation, maintaining mitochondrial metabolism in CAR T cells (MCAR T-1). These changes increase CD8 + T memory cells (Tm), enhancing persistence and anti-tumor activity in vitro and in xenograft models. GLP-1R knockdown in CAR T cells diminishes autophagy/mitophagy induction, confirming its critical role. We further engineer GLP-1-secreting cells (MCAR T-2), which exhibited sustained memory, stemness, and long-term persistence, even under tumor re-challenge. MCAR T-2 cells also reduce cytokine release syndrome (CRS) risks while demonstrating potent anti-tumor effects. This strategy highlights the potential of metabolic reprogramming via targeting autophagy/mitophagy pathways to improve CAR T cell therapy outcomes, ensuring durability and efficacy. • TR triggers CAR T cell decline, which is reversed by GLP-1RA/SG and UrA (MCAR T cells) • MCAR T cells synergistically rejuvenate function via autophagy/mitophagy • MCAR T cells ensure long-term persistence and cytotoxicity in pre-clinical models Akhtar et al. show that bioengineering CAR T cells with GLP-1R agonist and Urolithin A enhances autophagy/mitophagy, leading to improved persistence and anti-tumor activity. This approach offers a promising strategy to overcome CAR T cell exhaustion and improve therapeutic efficacy.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.xcrm.2025.102021
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Akhtar, A., Shakir, M., Ansari, M.S., Divya, Faizan, M.I., Chauhan, V., Singh, A., Alam, R., Azmi, I., Sharma, S., Pracha, M., Uddin, I.M., Bashir, U., Shahni, S.N., Chaudhuri, R.K., Albogami, S.M., Ganguly, R., Sagar, S., Singh, V.P., &amp; Kharya, G. (2025). Bioengineering the metabolic network of CAR T cells with GLP-1 and Urolithin A increases persistence and long-term anti-tumor activity. <em>Cell Reports Medicine</em>. https://doi.org/10.1016/j.xcrm.2025.102021
Vancouver
Akhtar A, Shakir M, Ansari MS, Divya, Faizan MI, Chauhan V, et al. Bioengineering the metabolic network of CAR T cells with GLP-1 and Urolithin A increases persistence and long-term anti-tumor activity. Cell Reports Medicine. 2025. doi:10.1016/j.xcrm.2025.102021.
BibTeX
@article{areej2025Bioeng, title = {Bioengineering the metabolic network of CAR T cells with GLP-1 and Urolithin A increases persistence and long-term anti-tumor activity}, author = {Areej Akhtar and Md Shakir and Mohammad Sufyan Ansari and Divya and Md Imam Faizan and Varnit Chauhan and Aashi Singh and Raquib Alam and Iqbal Azmi and Sheetal Sharma and Mehak Pracha and Insha Mohi Uddin and Uzma Bashir and Syeda Najidah Shahni and Rituparna Kundu Chaudhuri and Sarah M. Albogami and Rik Ganguly and Shakti Sagar and Vijay Pal Singh and Gaurav Kharya and Amit Kumar Srivastava and Ulaganathan Mabalirajan and Soumya Sinha Roy and Irfan Rahman and Tanveer Ahmad}, journal = {Cell Reports Medicine}, year = {2025}, doi = {10.1016/j.xcrm.2025.102021}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings